Caprolactam Chemicals Ltd Intrinsic Value
CAPRO · Commodities · Current price ₹49.84
Is Caprolactam Chemicals Ltd undervalued?
DocStoX estimates the fair value of Caprolactam Chemicals Ltd at ₹57 per share, versus the current market price of ₹50. That puts the stock about +14.6% below our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹9), Relative P/E (₹173), Graham floor (₹35). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹9 (bear) to ₹57 (base) to ₹173 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹50 versus an intrinsic value of ₹57, Caprolactam Chemicals Ltd currently offers +14.6% of margin.
More on Caprolactam Chemicals Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.